Mettler-Toledo International, Inc. (MTD) – What Are Researchers Thinking About This Stock?

Shares of Mettler-Toledo International, Inc. (NYSE:MTD) have received a consensus recommendation of “Hold” from the fifteen research firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $1,469.15.

Several equities analysts have recently weighed in on MTD shares. Barclays raised their price objective on Mettler-Toledo International from $1,575.00 to $1,700.00 and gave the company an “overweight” rating in a report on Wednesday, October 7th. Weiss Ratings upgraded Mettler-Toledo International from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, October 19th. Stifel Nicolaus increased their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday, August 3rd. UBS Group initiated coverage on Mettler-Toledo International in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $1,460.00 price target for the company. Finally, Royal Bank Of Canada began coverage on Mettler-Toledo International in a research report on Tuesday, September 1st. They set a “sector perform” rating and a $1,515.00 price target on the stock.

Mettler-Toledo International Price Performance

NYSE MTD opened at $1,676.02 on Tuesday. The business has a 50 day simple moving average of $1,494.69 and a 200 day simple moving average of $1,340.07. Mettler-Toledo International has a 52-week low of $1,023.05 and a 52-week high of $1,728.66. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12. The stock has a market cap of $33.59 billion, a price-to-earnings ratio of 37.72, a PEG ratio of 3.37 and a beta of 1.19.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 EPS for the quarter, beating analysts’ consensus estimates of $10.78 by $0.68. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%. The company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period in the previous year, the company posted $10.09 earnings per share. The company’s quarterly revenue was up 4.5% compared to the same quarter last year. Analysts anticipate that Mettler-Toledo International will post 47.38 earnings per share for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 240 shares of the stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $1,427.14, for a total transaction of $342,513.60. Following the sale, the insider directly owned 259 shares of the company’s stock, valued at approximately $369,629.26. This represents a 48.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Shawn Vadala sold 2,240 shares of Mettler-Toledo International stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $1,432.00, for a total value of $3,207,680.00. Following the completion of the transaction, the chief financial officer owned 5,579 shares in the company, valued at approximately $7,989,128. The trade was a 28.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 4,254 shares of company stock valued at $6,092,712. 0.71% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Mettler-Toledo International

A number of hedge funds and other institutional investors have recently made changes to their positions in MTD. Chicago Partners Investment Group LLC lifted its position in shares of Mettler-Toledo International by 11.7% in the third quarter. Chicago Partners Investment Group LLC now owns 344 shares of the medical instruments supplier’s stock worth $575,000 after buying an additional 36 shares in the last quarter. AIA Group Ltd grew its position in Mettler-Toledo International by 36.1% in the 3rd quarter. AIA Group Ltd now owns 22,774 shares of the medical instruments supplier’s stock valued at $34,410,000 after acquiring an additional 6,037 shares during the last quarter. Provenance Wealth Advisors LLC purchased a new stake in Mettler-Toledo International in the third quarter worth $54,000. Torray Investment Partners LLC increased its stake in Mettler-Toledo International by 0.7% in the third quarter. Torray Investment Partners LLC now owns 1,683 shares of the medical instruments supplier’s stock worth $2,543,000 after purchasing an additional 12 shares during the period. Finally, Garde Capital Inc. bought a new stake in shares of Mettler-Toledo International during the third quarter worth $227,000. 95.07% of the stock is owned by institutional investors and hedge funds.

About Mettler-Toledo International

Mettler-Toledo International Inc (NYSE: MTD) develops and manufactures precision instruments and related services for laboratory, industrial, and retail applications. Its products help customers weigh, measure, analyze, inspect, and control materials and processes with high accuracy.

The company’s laboratory offerings include balances and scales, analytical instruments, titration and pH systems, thermal analysis equipment, spectroscopy products, laboratory automation solutions, and associated software.